LL-37 Peptide Technical Deep Dive Purity Specifications Manufacturing Sourcing and Certification Guide
Executive Summary
LL-37 Peptide stands as a critical bioactive amphipathic helix in advanced research formulations, positioned for laboratories requiring precise antimicrobial peptide analogs. This technical deep dive examines purity specifications exceeding 98% verified by HPLC and mass spectrometry, manufactured under cGMP guidelines in ISO 9001 certified facilities. Sourcing from peptide synthesis specialists ensures batch-to-batch consistency, eliminating the common buyer pain point of variable bioactivity. The manufacturing standard employs solid-phase synthesis with rigorous endotoxin control, suitable for in vitro and ex vivo studies. Quality advantages include lyophilized powder stability and full certificate of analysis documentation. Researchers avoid the frustration of degraded samples or impure lots by selecting LL-37 with documented purity profiles, enabling reproducible data in immunology and dermatology research without medical claims.
Target Keyword: ll 37
Core Molecular Specs & Technical Index
The ll-37 peptide is a 37-amino acid cationic antimicrobial peptide (AMP) derived from the human cathelicidin protein (hCAP18). It is the only cathelicidin peptide found in humans and is widely recognized in the cosmetic and laboratory raw material sectors for its multifunctional properties. As a professional B2B ingredient, it serves formulators, contract manufacturers, and research institutions seeking high-purity bioactive peptides for advanced skincare and experimental applications. The core value of ll-37 peptide lies in its ability to support innate immune modulation and maintain skin barrier integrity, making it a critical component in high-end cosmetic formulations and immunological studies.
Below are the essential technical specifications that define premium-grade ll-37 peptide:
- Molecular Formula: C204H340N60O53 – a complex structure requiring precise solid-phase synthesis.
- Molecular Weight: 4493.3 Da – ensuring consistent batch-to-batch reproducibility.
- Purity Specification: ≥98% by HPLC (High-Performance Liquid Chromatography) – the industry benchmark for active peptide raw materials.
- Solubility: Soluble in water and PBS buffer at 1 mg/mL, with optimal reconstitution in sterile deionized water.
- Storage Conditions: Lyophilized powder stable at -20°C for 24 months; reconstituted solution must be used within 72 hours at 4°C.
Industry data from the Peptide Therapeutics Foundation indicates that over 85% of commercial peptide failures in cosmetic applications are linked to purity levels below 95%. For ll-37 peptide, maintaining ≥98% purity is non-negotiable for consistent bioactivity and formulation stability.
Manufacturing & Quality Control
The production of high-grade ll-37 peptide follows a rigorous multi-step process designed to eliminate impurities and ensure batch uniformity. Manufacturing begins with solid-phase peptide synthesis (SPPS) using Fmoc chemistry, which allows for precise amino acid chain assembly. After cleavage from the resin, the crude peptide undergoes preparative HPLC purification to achieve the target purity of ≥98%. Final quality control includes mass spectrometry (MS) for molecular weight confirmation and amino acid analysis (AAA) for sequence verification.
Third-party testing is mandatory for commercial-grade ll-37 peptide. Reputable suppliers provide Certificates of Analysis (CoA) from independent laboratories, covering:
- HPLC purity report with chromatogram
- Mass spectrometry (ESI-MS or MALDI-TOF) data
- Endotoxin level (≤1 EU/mg for cosmetic use)
- Residual solvent analysis (meeting ICH Q3C guidelines)
- Microbiological testing (total aerobic microbial count, yeast, and mold)
Certifications that distinguish premium ll-37 peptide suppliers include ISO 9001:2015 for quality management, GMP compliance for cosmetic ingredient manufacturing, and COSMOS or ECOCERT for organic formulation compatibility. For laboratory research, additional certifications such as MSDS (Material Safety Data Sheet) and stability studies under accelerated conditions (40°C/75% RH for 6 months) are essential.
Commercial Application Scenarios
ll-37 peptide is deployed across three primary commercial channels, each with distinct technical requirements:
Cosmetic Formulation: In anti-aging serums, moisturizers, and post-procedure care products, ll-37 peptide is incorporated at concentrations between 0.001% and 0.01%. It supports skin barrier function and modulates the cutaneous microbiome. Formulators must ensure the peptide is encapsulated or stabilized with antioxidants to prevent oxidation during shelf life. The peptide's amphipathic nature allows it to integrate into oil-in-water emulsions without compromising clarity.
Laboratory Research: For immunological studies, wound healing assays, and antimicrobial testing, ll-37 peptide is supplied in lyophilized form with endotoxin-free certification. Researchers typically reconstitute it in sterile PBS at 1 mg/mL and store aliquots at -80°C. The peptide's activity is validated using minimum inhibitory concentration (MIC) assays against E. coli and S. aureus.
Bulk Wholesale: Large-scale buyers (≥10 grams) require ll-37 peptide with documented batch consistency, stability data, and regulatory compliance for import/export. Wholesale customers often request custom packaging (e.g., argon-flushed vials) and accelerated stability studies to support their own product registration.
ll-37 peptide VS Ordinary Low-Grade Peptides
| Item | Our Product (Premium ll-37) | Alternatives (Low-Grade Peptides) | Advantages |
|---|---|---|---|
| Purity Level | ≥98% by HPLC | 70-90% by HPLC | Higher bioactivity, fewer side reactions |
| Endotoxin Content | ≤1 EU/mg | 5-20 EU/mg | Safe for cosmetic and sensitive applications |
| Batch Consistency | CV <5% across batches | CV >15% | Reliable formulation results |
| Stability Data | 24 months at -20°C | 6-12 months at -20°C | Longer shelf life, lower inventory risk |
Bulk Purchase Selection Guide
Procuring ll-37 peptide in bulk requires careful evaluation to avoid common pitfalls. The most frequent issues include receiving under-purified material, incorrect sequence (e.g., truncated peptides), or inadequate documentation for customs clearance. To mitigate these risks, follow this buyer checklist:
- Request a CoA from the manufacturer showing HPLC purity ≥98% and MS confirmation.
- Verify the supplier's ISO 9001:2015 certification and GMP compliance for cosmetic ingredients.
- Ask for stability data under real-time (4°C) and accelerated (40°C) conditions.
- Confirm endotoxin levels are ≤1 EU/mg for cosmetic use or ≤0.5 EU/mg for research.
- Ensure the peptide is supplied in airtight, light-protected vials with desiccant.
- Check for third-party testing from accredited labs (e.g., SGS, Eurofins).
- Request a sample batch (100 mg) for in-house validation before full-scale purchase.
Common pitfalls include assuming all ll-37 peptide is identical—variations in counterion (e.g., TFA vs. acetate salt) affect solubility and bioactivity. Always specify the salt form required for your application.
Core Product Advantages
Premium-grade ll-37 peptide offers distinct advantages over standard peptide raw materials. First, purity at ≥98% ensures maximum specific activity per milligram, reducing the required dosage in formulations and lowering overall production costs. Second, stability is enhanced through optimized lyophilization and packaging, providing a 24-month shelf life at -20°C without significant degradation. Third, cost performance is achieved through scalable manufacturing processes that maintain quality while offering competitive pricing for bulk orders. Finally, technical support from experienced suppliers includes formulation guidance, stability study design, and regulatory documentation assistance, enabling faster product development cycles for B2B clients.
Frequently Asked Questions
Q1: What is the minimum purity required for ll-37 peptide in cosmetic formulations?
For cosmetic applications, ll-37 peptide should have a minimum purity of 98% by HPLC. Lower purity may introduce truncated sequences or oxidation byproducts that reduce efficacy and increase the risk of formulation instability. Always request a CoA with the chromatogram to verify purity.
Q2: How should ll-37 peptide be stored to maintain activity during bulk storage?
Lyophilized ll-37 peptide must be stored at -20°C in airtight, light-protected vials with desiccant. Avoid repeated freeze-thaw cycles by aliquoting the peptide upon reconstitution. For long-term storage (over 12 months), -80°C is recommended. Reconstituted solutions should be used within 72 hours when stored at 4°C.
Q3: What documentation is required for importing ll-37 peptide for commercial use?
Importing ll-37 peptide requires a Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and a certificate of origin. For cosmetic use, additional documentation may include GMP compliance certificates and stability data. Always confirm with your supplier that they provide full regulatory support for customs clearance in your target market.